Shelton, David
Pfizer (United States)
4 papers on CoChat
Most cited papers
- Verified
Neurotrophins and Time: Different Roles for TrkB Signaling in Hippocampal Long-Term Potentiation
Kang, H., Welcher, A. A., Shelton, D., & Schuman, E. M. (1997) · Neuron
Neuroscience and Neuropharmacology ResearchNerve injury and regeneration
Cited by 481
- Verified
Blockade of Endogenous Ligands of TrkB Inhibits Formation of Ocular Dominance Columns
Cabelli, R. J., Shelton, D. L., Segal, R. A., & Shatz, C. J. (1997) · Neuron
Nerve injury and regenerationAxon Guidance and Neuronal Signaling
Cited by 306
- Verified
Characterization of proprotein convertase subtilisin/kexin type 9 (PCSK9) trafficking reveals a novel lysosomal targeting mechanism via amyloid precursor-like protein 2 (APLP2)
DeVay, R. M., Shelton, D. L., & Liang, H. (2013) · Journal of Biological Chemistry
Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health
Cited by 66
- Verified
Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
Panowski, S. H., Kuo, T. C., Zhang, Y., Chen, A., Geng, T., Aschenbrenner, L., Kamperschroer, C., Pascua, E., Chen, W., Delaria, K., et al. (2019) · Molecular Cancer Therapeutics
Multiple Myeloma Research and TreatmentsMonoclonal and Polyclonal Antibodies Research
Cited by 48
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free